- Home
- CELC vs WSFS Comparison
CELC vs WSFS Comparison
Compare CELC & WSFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CELC | WSFS |
|---|---|---|
| Founded | 2011 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.1B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | CELC | WSFS |
|---|---|---|
| Price | $110.32 | $57.74 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $100.13 | $64.25 |
| AVG Volume (30 Days) | ★ 629.3K | 308.1K |
| Earning Date | 11-12-2025 | 01-26-2026 |
| Dividend Yield | N/A | ★ 1.18% |
| EPS Growth | N/A | ★ 9.94 |
| EPS | N/A | ★ 4.83 |
| Revenue | N/A | ★ $1,011,052,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.22 |
| P/E Ratio | ★ N/A | $11.97 |
| Revenue Growth | N/A | ★ 4.02 |
| 52 Week Low | $7.58 | $42.44 |
| 52 Week High | $116.44 | $60.35 |
Technical Indicators
Market Signals| Indicator | CELC | WSFS |
|---|---|---|
| Relative Strength Index (RSI) | 60.08 | 54.48 |
| Support Level | $103.00 | $55.91 |
| Resistance Level | $112.69 | $60.35 |
| Average True Range (ATR) | 6.44 | 1.40 |
| MACD | 0.07 | 0.23 |
| Stochastic Oscillator | 70.07 | 52.78 |
Price Performance
Historical ComparisonAbout CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About WSFS WSFS Financial Corporation
WSFS Financial Corp is a savings and loan holding company. The company operates in three segments: WSFS Bank provides loans and leases and other financial products to commercial and consumer customers. Cash Connect segment provides ATM vault cash, smart safe, and other cash logistics services; and Wealth Management provides a broad array of planning and advisor services, investment management, personal and institutional trust services, and credit and deposit products to individuals, corporate, and institutional clients. Majority revenue is generated from WSFS Bank segment.